/Michael Shankman/

Insider Reports History

Location
Danville, CA
Signature
/Michael Shankman/
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by /Michael Shankman/:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexaria Bioscience Corp. Chief Financial Officer Stock Options 100,000 $122,000 $1.22 15 May 2025 Direct

Insider Reports Filed by /Michael Shankman/

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LEXX Lexaria Bioscience Corp. 15 May 2025 1 $0 4 Chief Financial Officer 16 May 2025, 16:51
LEXX Lexaria Bioscience Corp. 01 Oct 2024 0 $0 3 Chief Financial Officer 02 Oct 2024, 15:45